PDCD1 and neurodegenerative disease: In neurodegenerative diseases, the effect of blocking anti-PD-1/PD-L1 on mitigating brain pathology was associated with evoking an immune response in the periphery (outside the brain) which induced recruitment of specialized immune cells to the brain’s territory.